Who Is Elise Nassif Haddad: Inside the Life of Dr. Fadi Haddad’s Wife

Elise Nassif Haddad is more than the wife of another respected cancer specialist. She is a physician-scientist, medical oncologist and academic leader whose work focuses on rare and aggressive soft tissue cancers. At The University of Texas MD Anderson Cancer Center, she combines patient care with laboratory research, clinical trials and medical education.

Her journey connects advanced medical training in France with a growing career in the United States. She has developed particular expertise in leiomyosarcoma and undifferentiated pleomorphic sarcoma while studying how the immune system interacts with these tumours. Away from work, she shares her life with leukaemia specialist Dr. Fadi Haddad, whom she met during fellowship training at MD Anderson.

Quick Facts About Elise Nassif Haddad

Her current faculty record confirms her academic appointments, qualifications, research interests and professional service. Details about her marriage were shared by the couple in a published interview.

Who Is Elise Nassif Haddad?

Elise Nassif Haddad is an Assistant Professor in the Department of Sarcoma Medical Oncology at MD Anderson Cancer Center. She also holds a joint appointment in Investigational Cancer Therapeutics, linking her clinical practice with experimental drug development.

Her main focus is soft tissue sarcoma, a broad group of cancers that can begin in muscle, fat, nerves, blood vessels and other supporting tissues. She is especially interested in leiomyosarcoma and undifferentiated pleomorphic sarcoma.

Unlike a doctor whose work remains only in the clinic, she follows the physician-scientist model. She treats patients while also studying tumour biology, immune responses and possible new therapies.

Early Life and Background

Little verified information is available about her childhood, parents or exact birthplace. Her public biography is centred mainly on education, medical training and professional work.

What is known is that her early career developed in France. She studied medicine in Paris and trained at Gustave Roussy Cancer Center during residency and fellowship, gaining experience in specialised oncology care.

Her academic choices show a long-standing interest in combining medicine with science. After qualifying as a doctor, she continued into immunology, molecular oncology and translational cancer research rather than limiting her work to routine clinical practice.

Her Age and Physical Features

Elise Nassif Haddad has not publicly confirmed her birth date, so her exact age cannot be stated responsibly. Estimates based on graduation years are unreliable because students enter medical training at different ages.

Her official profiles include professional photographs but do not provide height, weight or body measurements. These details are not relevant to her medical achievements and have not been confirmed by credible sources.

In public appearances, she presents a polished and professional image. Her reputation is based on research, patient care and leadership rather than celebrity-style attention to physical appearance.

Education and Scientific Training

Elise Nassif Haddad earned her medical degree from Université Paris Descartes in 2014. She then completed residency and clinical fellowship training in medical oncology between 2014 and 2020.

While progressing through specialist training, she earned a Master of Science in Immunology in 2019. This qualification gave her a deeper understanding of how immune cells recognise, attack or sometimes fail to control cancer.

After finishing clinical training in France, she completed a research fellowship in translational immuno-oncology at MD Anderson from 2021 to 2022. Her work examined the sarcoma immune microenvironment and possible immune-based treatment targets.

In 2023, she received a Ph.D. in oncology from Université Claude Bernard Lyon 1. Her combination of an M.D., a master’s degree and a doctorate allows her to move between patient care, laboratory research and clinical trial design.

Career and Major Achievements

At MD Anderson, Elise Nassif Haddad works in both Sarcoma Medical Oncology and Investigational Cancer Therapeutics. Her main clinical and scientific interests include leiomyosarcoma, undifferentiated pleomorphic sarcoma, immunotherapy and sarcoma drug development.

She has also taken on educational and leadership duties. Since 2023, she has served as fellowship coordinator for the Department of Sarcoma Medical Oncology and has participated in the institution’s fellowship steering committee.

Her professional service extends beyond MD Anderson. Her faculty profile identifies her as chair of the Leiomyosarcoma Writing Subgroup for the ASCO Soft Tissue Sarcoma Guidelines and as co-chair of an executive committee connected with the National Leiomyosarcoma Foundation.

Her honours include the 2024 MD Anderson Rising Star Award, first place for clinical research at a Society for Immunotherapy of Cancer Sparkathon, the Daniel Benedict Gazan Award in Sarcoma Research and an ASCO/Conquer Cancer merit award.

Research on Sarcoma and Immunotherapy

The research led by Elise Nassif Haddad explores why some sarcomas respond to immunotherapy while others resist it. A tumour contains not only cancer cells but also immune cells, blood vessels and supporting tissue that can influence treatment response.

Her team has studied immune patterns in leiomyosarcoma samples. The goal is to identify distinct immune classes that may help doctors determine which patients could benefit from immunotherapy and which treatment combinations deserve further testing.

She has also supervised research examining ATRX loss in several sarcoma subtypes. That work investigated possible links between gene changes, survival and the tumour immune environment.

Clinical drug development is another major part of her work. She has presented early research involving gemcitabine and nab-sirolimus for advanced leiomyosarcoma and other soft tissue sarcomas with selected genetic alterations.

Relationship with Dr. Fadi Haddad

Elise Nassif Haddad is married to Dr. Fadi Haddad, an Assistant Professor in MD Anderson’s Department of Leukemia. His research focuses particularly on chronic myeloid leukaemia, acute lymphoblastic leukaemia and other blood cancers.

The couple met in 2020 during a virtual session for fellows training at MD Anderson. Both originally expected to return to their home countries after fellowship, but their relationship and new faculty opportunities changed those plans.

They later discovered that they lived in the same building and began spending more time together. After dating for about a year, they received separate faculty offers from MD Anderson within days of each other.

Their relationship is distinctive because both treat rare and serious cancers. That shared experience helps them understand difficult clinical days, emotionally demanding conversations and the uncertainty that often accompanies research.

Marriage and Family Life

The doctors married in 2023 and chose to build their lives in the United States. Although they work in different departments, their expertise can overlap when a patient faces both a sarcoma and a blood-related cancer.

They have described supporting each other after difficult days in the hospital. Because both understand the responsibility of delivering serious news, they can discuss experiences that may be hard to explain to someone outside medicine.

Their partnership also includes professional support. They exchange ideas, review research proposals and celebrate successful studies while encouraging one another when a project does not produce the expected result.

Despite public curiosity, they maintain a relatively private home life. Most reliable personal details come from professional interviews rather than entertainment coverage.

Does Elise Nassif Haddad Have Children?

In a February 2025 interview, Elise Nassif Haddad and her husband said they were expecting their first child. The couple joked about whether the child might one day choose between sarcoma and leukaemia as a speciality.

More recent institutional sources do not provide detailed family updates. It is therefore safer to state only that the pregnancy was publicly announced rather than publish unconfirmed claims about a child’s name, birth date or present circumstances.

This distinction protects family privacy. Interest in a doctor’s public career does not justify spreading unsupported information about a minor.

Personality and Interests

Public interviews present Elise Nassif Haddad as thoughtful, collaborative and deeply committed to patient care. Her career combines scientific precision with the empathy required to support people facing rare and aggressive cancers.

Her work in fellowship coordination and research supervision also shows a strong interest in mentoring younger doctors. She has guided conference research and serves in positions that influence oncology education and treatment guidance.

Collaboration appears to be one of her central professional values. Her projects bring together oncologists, surgeons, pathologists, immunologists, fellows and patient organisations.

Her private hobbies are not widely documented. It would therefore be misleading to assign personal interests she has not publicly discussed.

Social Media Presence

Elise Nassif Haddad has a professional online presence, including a LinkedIn profile connected with her work at MD Anderson. Her public activity focuses mainly on oncology research, professional events and developments in the sarcoma community.

She does not appear to use social media as a lifestyle influencer. Her digital identity is based on academic networking, cancer education and professional communication.

This measured approach fits her role as a physician-scientist. It allows colleagues and interested members of the public to follow her work while keeping most of her private life outside the spotlight.

Net Worth and Income

No reliable public record confirms the net worth of Elise Nassif Haddad. Exact figures published by unsourced biography sites should be treated as estimates rather than established facts.

Her income is likely connected with her faculty appointment, clinical responsibilities, teaching, research and academic service. However, her exact salary and additional compensation have not been publicly confirmed.

A specific dollar figure would therefore be misleading. Her professional standing is better measured through patient care, research output, leadership roles and contributions to medical education.

Public Image and Legacy

Elise Nassif Haddad is building a reputation as an emerging leader in rare cancer medicine. Her awards, guideline responsibilities and academic appointments reflect growing recognition of her clinical and scientific work.

Her contribution is important because rare sarcomas are difficult to study in large populations. Progress often depends on collaboration, careful analysis of tumour samples and the ability to connect discoveries across institutions.

A lasting part of her legacy may be the effort to make sarcoma treatment more precise. By identifying immune and molecular features, her research could help doctors choose treatments according to tumour biology rather than broad disease labels.

Her mentorship may also have long-term value. The fellows and junior researchers she supports can carry new ideas into future studies and patient care.

Future Plans

Elise Nassif Haddad has not published a fixed personal roadmap, but her active research record shows an ongoing focus on leiomyosarcoma, immunotherapy and new drug combinations. Recent presentations and committee roles suggest that clinical trials and translational research will remain central to her career.

Future work may expand the use of biomarkers to group patients more accurately. It may also explore combinations designed to make immune-based treatment effective for tumours that currently respond poorly.

Education and professional leadership are likely to remain important as well. Her roles in fellowship coordination and treatment-guideline development place her in a strong position to influence future specialists and standards of care.

Conclusion

Elise Nassif Haddad has built a career that combines medicine, immunology, research and teaching. From her training in France to her faculty role at MD Anderson, she has remained focused on improving care for people with rare soft tissue cancers.

Her marriage to Dr. Fadi Haddad adds an interesting personal dimension, but it does not define her identity. She is an accomplished oncologist whose work may contribute to more individualised and effective sarcoma treatment.

As her clinical studies, collaborations and leadership responsibilities grow, Elise Nassif Haddad is positioned to make a lasting contribution to oncology. Her story reflects scientific discipline, professional ambition and a patient-centred approach to one of medicine’s most demanding fields.

FAQs About Elise Nassif Haddad

Who is Elise Nassif Haddad?

Elise Nassif Haddad is a physician-scientist and Assistant Professor in the Department of Sarcoma Medical Oncology at MD Anderson Cancer Center.

Who is Elise Nassif Haddad married to?

Elise Nassif Haddad is married to Dr. Fadi Haddad, an Assistant Professor in the Department of Leukemia at MD Anderson.

What type of cancer does Elise Nassif Haddad treat?

Dr. Haddad specialises in rare soft tissue cancers, including leiomyosarcoma and undifferentiated pleomorphic sarcoma.

Where did Elise Nassif Haddad study medicine?

Elise Nassif Haddad earned a medical degree from Université Paris Descartes and later completed advanced studies in immunology and oncology.

Does Elise Nassif Haddad have children?

Elise Nassif Haddad and Dr. Fadi Haddad announced in February 2025 that they were expecting their first child. Further family details remain private.

What is Elise Nassif Haddad’s net worth?

No reliable source has confirmed the personal net worth of Elise Nassif Haddad. Exact figures published online should be treated as estimates.

What awards has Elise Nassif Haddad received?

Major honours include the MD Anderson Rising Star Award, the Daniel Benedict Gazan Award in Sarcoma Research and recognition for clinical research.

What is Elise Nassif Haddad’s main research focus?

The main research focus includes sarcoma immunotherapy, tumour biomarkers, the immune microenvironment and the development of new cancer treatments.